Arlo Technologies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Arlo Technologies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Arlo Technologies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 29, 2024 was $9.51M, a 22% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $9.51M -$2.68M -22% Sep 29, 2024 10-Q 2024-11-07
Q2 2024 $10.2M -$847K -7.64% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.7M -$1.29M -10.7% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.5M -$1.36M -10.6% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $12.2M -$1.97M -13.9% Oct 1, 2023 10-Q 2023-11-09
Q2 2023 $11.1M -$4.15M -27.2% Jul 2, 2023 10-Q 2023-08-10
Q1 2023 $12M -$1.81M -13.1% Apr 2, 2023 10-Q 2023-05-11
Q4 2022 $12.8M -$2.01M -13.5% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $14.2M -$1.46M -9.34% Oct 2, 2022 10-Q 2022-11-09
Q2 2022 $15.2M +$94K +0.62% Jul 3, 2022 10-Q 2022-08-10
Q1 2022 $13.8M -$9.15M -39.9% Apr 3, 2022 10-Q 2022-05-11
Q4 2021 $14.8M -$9.18M -38.3% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $15.6M -$9.41M -37.6% Oct 3, 2021 10-Q 2021-11-10
Q2 2021 $15.1M -$10.9M -41.8% Jun 27, 2021 10-Q 2021-08-05
Q1 2021 $23M -$7.23M -24% Mar 28, 2021 10-Q 2021-05-06
Q4 2020 $24M -$7.3M -23.3% Dec 31, 2020 10-K 2022-03-02
Q3 2020 $25M -$6.98M -21.8% Sep 27, 2020 10-Q 2020-11-05
Q2 2020 $26M -$6.61M -20.2% Jun 28, 2020 10-Q 2020-08-06
Q1 2020 $30.2M +$3.15M +11.7% Mar 29, 2020 10-Q 2020-05-11
Q4 2019 $31.3M +$31.3M Dec 31, 2019 10-K 2021-02-26
Q3 2019 $32M Sep 29, 2019 10-Q 2019-11-08
Q2 2019 $32.7M Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $27M Mar 31, 2019 10-Q 2019-05-06
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.